Results 1 to 10 of about 300,974 (236)
Tremor and Other Hyperkinetic Movements, 2012 Background: It is generally agreed that diffusion of botulinum toxin occurs, but the extent of the spread and its clinical importance are disputed.
Matthew A. Brodsky +2 more
doaj +7 more sources
Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins. [PDF]
Toxins (Basel), 2020 Blepharospasm and oromandibular dystonia are focal dystonias characterized by involuntary and often patterned, repetitive muscle contractions. There is a long history of medical and surgical therapies, with the current first-line therapy, botulinum ...
Hassell TJW, Charles D.
europepmc +2 more sources
FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia. [PDF]
Toxins (Basel), 2020 In 2016, the American Academy of Neurology (AAN) published practice guidelines for botulinum toxin (BoNT) in the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. This article, focusing on dystonia, provides context for these
Spiegel LL, Ostrem JL, Bledsoe IO.
europepmc +2 more sources
Immunogenicity of botulinum toxins [PDF]
Journal of Neural Transmission, 2012 Botulinum neurotoxins are formulated biologic pharmaceuticals used therapeutically to treat a wide variety of chronic conditions, with varying governmental approvals by country.
M. Naumann +3 more
semanticscholar +4 more sources
Botulinum toxins for the prevention of migraine in adults. [PDF]
Cochrane Database Syst Rev, 2018 BACKGROUND Migraine occurs in around 15% of adults and is ranked as the seventh most disabling disease amongst all diseases globally. Despite the available treatments many people suffer prolonged and frequent attacks which have a major impact on their ...
Herd CP +7 more
europepmc +2 more sources
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
Toxins, 2021 Botulinum toxin is a superfamily of neurotoxins produced by the bacterium Clostridium Botulinum with well-established efficacy and safety profile in focal idiopathic hyperhidrosis.
Emanuela Martina +4 more
doaj +2 more sources
Indian Journal of Dermatology, 2010 Botulinum toxin, one of the most poisonous biological substances known, is a neurotoxin produced by the bacterium Clostridium botulinum. C. botulinum elaborates eight antigenically distinguishable exotoxins (A, B, C 1 , C 2 , D, E, F and G).
Nigam P, Nigam Anjana
doaj +3 more sources
Frontal fibrosing alopecia development in two patients after botulinum toxin applications: relationship or coincidence? [PDF]
Surgical & Cosmetic Dermatology, 2021 Frontal fibrous alopecia is a primary lymphocytic scarring alopecia that is difficult to control, with a perifollicular lichenoid infiltrate marking its histology.
Mariana Abdo de Almeida +2 more
doaj +1 more source
Immunogenicity of botulinum toxin [PDF]
Archives of Plastic Surgery, 2022 Botulinum toxin treatment is the most common non-surgical cosmetic treatment. Although there are many available treatments using botulinum toxin, their effects are temporary and repeated injections are required. These frequent injections can trigger an immunological response. In addition, botulinum toxin acts as an antigen in the body; thus, its effect
Syeo Young Wee, Eun Soo Park
openaire +3 more sources
Use of botulinum toxin in hidradenitis suppurativa [PDF]
Surgical & Cosmetic Dermatology, 2021 Introduction: Hidradenitis suppurativa (HS) is an inflamatory, chronic, recurrent, and debilitating condition. There is a lack of consensus about its treatment.
Elcilane Gomes Silva +2 more
doaj +1 more source